Skip to main content
. Author manuscript; available in PMC: 2009 Mar 16.
Published in final edited form as: Neuroscience. 2005;130(2):383–388. doi: 10.1016/j.neuroscience.2004.09.012

Fig. 3. Examples of mPER1 immunoreactivity in whole brain in mice.

Fig. 3

(A) Treated with control ODN (top: mPER1; bottom: actin). mPER1 immunoreactivity of mice treated with control ODN started to rise in the late morning, reached its maximum around the usual time of ZT8, and then declined. (B) Treated with DNAzyme (top: mPER1; bottom: actin). The mPER1 immunoreactivity of mice treated with DNAzyme was arrhythmic and lower than that of mice treated with control ODN.